|
|
Aimee Y. Yu, Larissa A. Shimoda, Narayan V. Iyer, David L. Huso, Xing Sun, Rita McWilliams, Terri Beaty, James S.K. Sham, Charles M. Wiener, J.T. Sylvester, Gregg L. Semenza
J Clin Invest. 1999;
103(5):691
doi:10.1172/JCI5912
Abstract |
Full text
| PDF

C
hronic hypoxia induces polycythemia, pulmonary hypertension, right ventricular hypertrophy, and weight loss. Hypoxia-inducible factor 1 (HIF-1) activates transcription of genes encoding proteins that mediate adaptive responses to hypoxia, including erythropoietin, vascular endothelial growth factor, and glycolytic enzymes. Expression of the HIF-1α subunit increases exponentially as O2 concentration is decreased. Hif1a–/– mouse embryos with complete deficiency of HIF-1α due to homozygosity for a null allele at the Hif1a locus die at midgestation, with multiple cardiovascular malformations and mesenchymal cell death. Hif1a+/– heterozygotes develop normally and are indistinguishable from Hif1a+/+ wild-type littermates when maintained under normoxic conditions. In this study, the physiological responses of Hif1a+/– and Hif1a+/+ mice exposed to 10% O2 for one to six weeks were analyzed. Hif1a+/– mice demonstrated significantly delayed development of polycythemia, right ventricular hypertrophy, pulmonary hypertension, and pulmonary vascular remodeling and significantly greater weight loss compared with wild-type littermates. These results indicate that partial HIF-1α deficiency has significant effects on multiple systemic responses to chronic hypoxia.J. Clin. Invest. 103:691–696 (1999)
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(119)
| Title and authors |
Publication |
Year |
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
E. M. Abud, J. Maylor, C. Undem, A. Punjabi, A. L. Zaiman, A. C. Myers, J. T. Sylvester, G. L. Semenza, L. A. Shimoda
|
Proceedings of the National Academy of Sciences
|
2012 |
Hypoxia-Inducible Factors in Physiology and Medicine
Gregg L. Semenza
|
Cell
|
2012 |
Gaseous messengers in oxygen sensing
Nanduri R. Prabhakar, Gregg L. Semenza
|
J Mol Med
|
2012 |
Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor
Dan-Dan Han, Yun Wang, Xin-Hua Zhang, Jin-Rong Liu, Huai-Liang Wang
|
Can. J. Physiol. Pharmacol.
|
2012 |
Advances in Pharmacology
Michael Koeppen, Tobias Eckle, Holger K. Eltzschig
|
Pharmacology of Purine and Pyrimidine Receptors
|
2011 |
The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma
S K Martin, P Diamond, S Gronthos, D J Peet, A C W Zannettino
|
Leukemia
|
2011 |
HIF prolyl hydroxylase inhibitors for anemia
Eugene Muchnik, Joshua Kaplan
|
Expert Opin. Investig. Drugs
|
2011 |
Vascularizing the heart
P. R. Riley, N. Smart
|
Cardiovascular Research
|
2011 |
Hypoxia-inducible factor 2α (HIF-2α) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension.
Ying-Jie Peng, Jayasri Nanduri, Shakil A Khan, Guoxiang Yuan, Ning Wang, Brian Kinsman, Damodara R Vaddi, Ganesh K Kumar, Joseph A Garcia, Gregg L Semenza, Nanduri R Prabhakar
|
Proc. Natl. Acad. Sci. U.S.A.
|
2011 |
Comprehensive Physiology
Ayako Makino, Amy L. Firth, Jason X.-J. Yuan
|
Comprehensive Physiology
|
2011 |
|